Navigation Links
Young Innovations, Inc. Announces Results for 4th Quarter and the Year and Declares Dividend
Date:2/4/2009

ense of $0.11 and $0.08 for 2008 and 2007, respectively.

Consistent with the third quarter, fourth quarter demand for our consumable products continued to be strong and was offset by weak performance in our diagnostic product line. Our consumable products, which include our preventive, infection control, applicator and home care product lines, posted solid growth in the quarter. Our diagnostic product line posted disappointing results, with revenue $1.6 million below that for the fourth quarter of 2007. We believe this product line continues to be negatively affected by on-going economic uncertainty, as we witnessed a significant increase in purchase deferrals. A stronger U.S. dollar negatively impacted sales by approximately $160,000 in the quarter. For the year, a weaker U.S. dollar provided a benefit to sales of approximately $474,000.

The gross margin for the quarter was negatively impacted by product mix and by an adjustment implemented in the quarter which reallocated approximately $130,000 in expense from selling, general and administrative into cost of goods sold. Because this adjustment was a reallocation of a full year of expense in the fourth quarter, it impacted the comparability of the fourth quarter gross margin to prior periods and made the fourth quarter gross margin lower than it would have been had we made the adjustment over the course of the year; the adjustment had no effect on the quarter's operating margin. We were generally pleased with the operating margin for the quarter, as we carefully managed expenses given the uncertain economic environment, adjusted staffing levels in certain areas of the business and began to realize the benefits of the facility consolidations we have implemented over the past two years.

We continued to make progress in implementing our strategy in the fourth quarter. We added new products to several of our product lines, including a fully integ
'/>"/>

SOURCE Young Innovations, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related medicine news :

1. Prestigious fellowship for young Nottingham researcher
2. Heavy marijuana use may damage developing brain in teens, young adults
3. University of Alberta organic chemist receives top young Canadian scientist prize
4. Quick Orthopedic Repair Can Save Young Shoulders
5. Immediate Orthopaedic Care Can Help Heal a Young Athletes Shoulder
6. Study finds genetic link between sleep disorders and depression in young children
7. Young Innovations, Inc. Provides Fourth Quarter Conference Call Details
8. Study shows younger women with endometrial cancer can safely keep ovaries, avoid early menopause
9. Assessing the real risk of heart disease in young people with low short-term risks
10. Light Sciences Oncology Elects Former FDA Commissioner Frank Young, M.D., Ph.D., to Board of Directors
11. Gene Variant Raises Risk for Brain Cancer at Young Age
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... 2013 For more than forty years, ... battle against drug and alcohol abuse around the world. ... first guide to help Italian speakers reverse growing trends ... European Monitoring Centre for Drugs and Drug Addiction show ... cannabis in the last year. As a glimpse of ...
(Date:5/20/2013)... child whose mother lived near heavy traffic while pregnant ... infection before the age of 3, a new study ... pairs of mothers and infants from eastern Massachusetts. All ... trimester of pregnancy at some point between 1999 and ... within 100 meters (about 110 yards) from a major ...
(Date:5/20/2013)... Posterior fossa subdural hematoma (PFSDH) is a serious and ... But with appropriate treatment, there,s an excellent chance of ... reports a study in the May issue of ... Congress of Neurological Surgeons . The journal is published ... of Wolters Kluwer Health . , The results ...
(Date:5/20/2013)... As high schoolers prepare for final exams, teens ... -- a prescription stimulant or amphetamine -- to gain ... poll shows only one in 100 parents of teens ... a study drug., Study drugs refer to stimulant medications ... disorder (ADHD); commonly prescribed medicines in this category include ...
(Date:5/20/2013)... three out of four pregnant women experience constipation, diarrhea ... University Medical Center study has found. , But such ... quality of life, the study found. , The study ... was presented during the American Congress of Obstetricians and ... One hundred and four pregnant women were enrolled and ...
Breaking Medicine News(10 mins):Health News:First Narconon Cannabis Abuse Prevention Guide Takes Aim at Drug Abuse Statistics for Italian Youth 2Health News:Living Near Major Roadways in Pregnancy Tied to Respiratory Woes in Children 2Health News:Study supports 'aggressive' treatment for posterior fossa hematoma in newborns 2Health News:Study supports 'aggressive' treatment for posterior fossa hematoma in newborns 3Health News:1 in 10 teens using 'study drugs,' but parents aren't paying attention 2Health News:72 percent of pregnant women experience constipation and other bowel problems 2
... has confirmed the presence of H5N1 bird flu strain in ... of the deadly bird flu strain // in six villages ... ,Early this month five new cases of bird ... flu was first detected in Danube delta in Romania this ...
... has been passed in United Kingdom which allows prescription ... 12 and pregnant women as the risk associated with ... nicotine patches as earlier the sale of nicotine patches ... women and people with chronic diseases such as heart, ...
... The first Chinese outbreak of H5N1 bird flu infection occurred ... thursday the Chinese officials have confirmed // the seventh death ... Zhou was a 41 year old women factory worker of ... and pneumonia, who had an initial H5N1 virus test negative. ...
... from injury tissue by increasing the number of circulating ... ,The report, to be published in the April ... Physiology, says a typical course of hyperbaric oxygen treatments ... patient`s body by eight-fold. ,Stem cells, also ...
... has indicated that China might be using "substandard poultry vaccine", ... deadly outbreaks of bird flu //in that country. ... Memphis, Tennessee, however said that this problem was not confined ... blame China for substandard vaccines. I think there are substandard ...
... As a coin has two sides so does vitamin D, it ... and liver. If taken in high doses vitamin D can be ... based on intakes from 63 studies. , ,The study was ... Garland looked at the relationship between blood levels of Vitamin D ...
Cached Medicine News:
(Date:5/20/2013)... CHICAGO, Ill. , May 20, 2013 /PRNewswire/ ... the initiation of a Phase 3 clinical study ... to assess the effects of the investigational compound ... progression of kidney disease in patients with stage ... type 2 diabetes.  SONAR is a large, multinational, ...
(Date:5/19/2013)...  The non-surgical Stretta® procedure employing ... is effective in control of gastroesophageal reflux disease ... medication 10 years post-procedure, according to an independent, ... Disease Week (DDW) meeting May 18-21, 2013 in ... "The sustained improvement in GERD-HRQL scores and ...
(Date:5/17/2013)... SHANGHAI , May 17, 2013 Medical ... drug nor a biological product. In light of their ... trail evaluations are much more complicated than drug trails ... only evaluates MD safety instead of evaluating both safety ... the US FDA (which is the same as the ...
Breaking Medicine Technology:AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 2AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 3AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 4AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 5AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 6Stretta Procedure for GERD: Successful 10 Year Follow-Up Data Presented at Digestive Disease Week--Sustained Improvement, Long-Term Efficacy 2Stretta Procedure for GERD: Successful 10 Year Follow-Up Data Presented at Digestive Disease Week--Sustained Improvement, Long-Term Efficacy 3Statistical Challenges in Medical Device Trail Evaluation 2
... Advanced Life Sciences,Holdings, Inc. (Nasdaq: ADLS ... with the National Institute of Allergy and ... biodefense,research, under which the NIAID will conduct ... as a treatment for,anthrax and other high-priority ...
... Double-Blind Study Targets Biomarker-Defined Population, BERKELEY ... GNTA ) announced that the first ... Phase 3 trial of Genasense,(oblimersen sodium) Injection ... is a randomized, double-blind, placebo-controlled study in ...
Cached Medicine Technology:Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents 2Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents 3Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents 4Genta Initiates Phase 3 AGENDA Trial of Genasense(R) for Patients with Advanced Melanoma 2Genta Initiates Phase 3 AGENDA Trial of Genasense(R) for Patients with Advanced Melanoma 3Genta Initiates Phase 3 AGENDA Trial of Genasense(R) for Patients with Advanced Melanoma 4Genta Initiates Phase 3 AGENDA Trial of Genasense(R) for Patients with Advanced Melanoma 5
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: